3Hashimoto K, Yasukawa M, Tohygama M. Human herpesvirus 6 and drug allerge[J]. Curt. Opin Allergy Clin Immunol, 2003, 3 (4) :255 -260.
4Lown KS, Thunnel KE, Benedict PE, et al. The erythromycin breath test predicts the clearance of midazolam [ J ]. Clin Pharmacol Ther, 1995; 57(1) :16 -24.
5Turgeon DK, Normolle DP, Leichtman AB, et al. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients[J]. Clin Pharmacol Ther, 1992; 52(5) :471 - 478.
6Kerr BM, Thummel KE, Wurden C J, et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11 -epoxide formation. Biochem Pharmacol [ J]. 1994 Jun 1 ; 47 ( 11 ) : 1969 - 1979.
7Tomson T, Bertilsson L. Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia [ J ]. Arch Neurol, 1984, 41 (6) :598 -601.
8Rebbeck TR, Jaffe JM, Walker AH, et al. Modiffication of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4[J]. J Nat Cancer Inst,1998,90(16) :1225 -1229.
9Westlind A, Lofberg L, Tindberg N, et al. Interindividual differences in hepatic expression of CYP3A4 : relationship to genetic polymorphism in the 5 ' -up-Stream regulatory region [ J ]. Biochem Biophys Res Commen, 1999,259( 1 ) :201 -205.
10Desoky ES, Fuseau E, Amry S, et al. Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients [ J ]. Eur J Clin Pharmacol, 2004,59 ( 11 ) :783 - 790.
